UVA researcher Blandine Baffert, working in the lab of UVA Health’s Sanja Arandjelovic and collaborating with researchers in ...

Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, double-blind, adaptive platform clinical trial ...

Scientists at the University of Virginia say they may be one step closer to stopping a rare and deadly disease that hardens ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

Scleroderma is an autoimmune, rheumatic, and chronic disease that affects the body by hardening connective tissue, according to the Johns Hopkins Scleroderma Center. For the almost 500,000 people in ...

Mycophenolate mofetil shows similar disease control to methotrexate in children with juvenile localized scleroderma, with ...

AMHERST, Va. (WDBJ) - Scleroderma is an often life-threatening inflammatory and vascular disease in which the body’s immune system attacks its own tissue. In its most aggressive form, the lungs, heart ...

SAN FRANCISCO--(BUSINESS WIRE)--The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Sanofi will contribute the first ...

Q: Would you define scleroderma? What are the early symptoms? Are there any tests to diagnose it? A: Scleroderma, or hard skin, isn't a common disorder. In a metropolitan area the size of St. Louis, ...

Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to thicken and harden because of the overproduction of a protein called collagen.

Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology. Characterized by ...